Constantino defies Cramer on pharma stocks: Buy

Mad Money host Jim Cramer has not gotten the last word on his recent advice to investors to sell their big pharma stocks. Seeking Alpha contributor Frank Constantino says if investors shift to defensive sectors, big pharma will rise again. So it's worth the wait. His top four picks: Eli Lilly, Bristol-Myers Squibb, Abbott Labs and Johnson & Johnson. Column

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.